General Information
Drug ID
DR00546
Drug Name
Cefixime
Synonyms
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethyloxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(carboxymethyl)oxy]imino}acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6r,7r)-7-[-2-(2-amino-thiazol-4-yl)-2-carboxymethoxyimino-acetylamino]-8-oxo-3-vinyl-5-thia-1-aza-b; 7beta-{(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido}-3-ethenyl-3,4-didehydrocepham-4-carboxylic acid; CFIX; CL-284635; Cefixima; Cefixime (JP15/USP/INN); Cefiximum; Denvar; FK-027; FR-17027; Necopen; Ofex (TN); Suprax (TN); Tricef
Drug Type
Small molecular drug
Indication Streptococcus bacterial infections [ICD11: 1C41] Approved [1]
Therapeutic Class
Antibiotics
Structure
3D MOL 2D MOL
Formula
C16H15N5O7S2
Canonical SMILES
C=CC1=C(N2C(C(C2=O)NC(=O)C(=NOCC(=O)O)C3=CSC(=N3)N)SC1)C(=O)O
InChI
InChI=1S/C16H15N5O7S2/c1-2-6-4-29-14-10(13(25)21(14)11(6)15(26)27)19-12(24)9(20-28-3-8(22)23)7-5-30-16(17)18-7/h2,5,10,14H,1,3-4H2,(H2,17,18)(H,19,24)(H,22,23)(H,26,27)/b20-9-/t10-,14-/m1/s1
InChIKey
OKBVVJOGVLARMR-QSWIMTSFSA-N
CAS Number
CAS 79350-37-1
Pharmaceutical Properties Molecular Weight 453.5 Topological Polar Surface Area 238
Heavy Atom Count 30 Rotatable Bond Count 8
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 12
XLogP
-0.7
PubChem CID
5362065
PubChem SID
103567682 , 104133792 , 114149638 , 11654000 , 117664404 , 12012851 , 121363201 , 124800909 , 126625637 , 126656766 , 126667588 , 134337735 , 135601356 , 135693789 , 137100974 , 137240061 , 143493269 , 14833440 , 151994359 , 152100554 , 152242797 , 15404783 , 162258044 , 163426477 , 164196526 , 174560966 , 175265490 , 175611868 , 179116601 , 184812415 , 198991919 , 203356010 , 39384388 , 46508684 , 47288991 , 47362877 , 47957436 , 48415714 , 49699091 , 50070784 , 50124237 , 57362078 , 7847324 , 78846797 , 7978875 , 85148376 , 85661978 , 85788072 , 9098 , 92712349
ChEBI ID
CHEBI:472657
TTD Drug ID
D06OVY
DT(s) Transporting This Drug PEPT1 Transporter Info Peptide transporter 1 Substrate [2]
PEPT2 Transporter Info Peptide transporter 2 Substrate [3]
PEPT2 Transporter Info Peptide transporter 2 Substrate [3]
References
1 Cefixime was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Flavonoids with epidermal growth factor-receptor tyrosine kinase inhibitory activity stimulate PEPT1-mediated cefixime uptake into human intestinal epithelial cells. J Pharmacol Exp Ther. 2001 Oct;299(1):351-7.
3 Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives. J Pharmacol Exp Ther. 2006 Jul;318(1):455-60.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.